{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:04:01Z","timestamp":1793754241203,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["24POST1189614"],"award-info":[{"award-number":["24POST1189614"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jhepr.2025.101369","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T17:07:13Z","timestamp":1740589633000},"page":"101369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Thyroid dysfunction in MASLD: Results of a nationwide study"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5055-5627","authenticated-orcid":false,"given":"Shuai","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-966X","authenticated-orcid":false,"given":"Fahim","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4808-1762","authenticated-orcid":false,"given":"David","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Vujkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Scorletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixin","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-1759","authenticated-orcid":false,"given":"Hannes","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-5602","authenticated-orcid":false,"given":"Jonas F.","family":"Ludvigsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101369_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101369_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101369_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101369_bib4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/thy.2018.0664","article-title":"Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists","volume":"29","author":"Sinha","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.jhepr.2025.101369_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fendo.2017.00335","article-title":"Relationship between hypothyroidism and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"8","author":"He","year":"2017","journal-title":"Front Endocrinol"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101369_bib6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1089\/thy.2018.0257","article-title":"Association between primary hypothyroidism and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"28","author":"Mantovani","year":"2018","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101369_bib7","article-title":"Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: korea National Health and Nutrition Examination Survey 2013 to 2015","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2025.101369_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101369_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ueg2.12124","article-title":"Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany","volume":"9","author":"Labenz","year":"2021","journal-title":"United Eur Gastroenterol J"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101369_bib10","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1210\/jc.2016-1300","article-title":"Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam Study","volume":"101","author":"Bano","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2025.101369_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"European association for the study of diabetes (EASD), European association for the study of obesity (EASO). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"43","key":"10.1016\/j.jhepr.2025.101369_bib12","doi-asserted-by":"crossref","first-page":"E9172","DOI":"10.1073\/pnas.1707797114","article-title":"Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms","volume":"114","author":"Ferrandino","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"23","key":"10.1016\/j.jhepr.2025.101369_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312797","article-title":"Hypothyroidism-associated dyslipidemia: potential molecular mechanisms leading to NAFLD","volume":"22","author":"Mavromati","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.jhepr.2025.101369_bib14","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.3390\/ijms21165927","article-title":"Hypothyroidism-induced nonalcoholic fatty liver disease (HIN): mechanisms and emerging therapeutic options","volume":"21","author":"Tanase","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101369_bib15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.tem.2022.08.001","article-title":"NAFLD and thyroid function: pathophysiological and therapeutic considerations","volume":"33","author":"Hatziagelaki","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2025.101369_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CLEP.S191914","article-title":"Cohort profile: ESPRESSO (Epidemiology strengthened by histoPathology reports in Sweden)","volume":"11","author":"Ludvigsson","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101369_bib17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101369_bib18","series-title":"KVAST dokument br\u00f6sttum\u00f6rer","author":"Grabau","year":"2014"},{"key":"10.1016\/j.jhepr.2025.101369_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/CLEP.S90589","article-title":"Ethical aspects of registry-based research in the Nordic countries","volume":"7","author":"Ludvigsson","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101369_bib20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101369_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101369_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jhepr.2025.101369_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103170","article-title":"Older age of celiac disease diagnosis and risk of autoimmune disease: a nationwide matched case-control study","volume":"143","author":"Yuan","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhepr.2025.101369_bib24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhepr.2025.101369_bib25","series-title":"Mediation: R package for causal mediation analysis","author":"Tingley","year":"2014"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101369_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-44701-9","article-title":"Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications","volume":"15","author":"Sterenborg","year":"2024","journal-title":"Nat Commun"},{"issue":"6706","key":"10.1016\/j.jhepr.2025.101369_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj1182","article-title":"Diversity and scale: genetic architecture of 2068 traits in the VA Million Veteran Program","volume":"385","author":"Verma","year":"2024","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101369_bib28","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic\u00a0associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101369_bib29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in\u00a0two-sample Mendelian randomization","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101369_bib30","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101369_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","article-title":"Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101369_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/hmg\/ddy327","article-title":"Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry","volume":"28","author":"Pulit","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101369_bib33","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","article-title":"Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis","volume":"52","author":"Vujkovic","year":"2020","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101369_bib34","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101369_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101369_bib36","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101369_bib37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101369_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1399517","article-title":"Association between thyroid function and nonalcoholic fatty liver disease: a dose-response meta-analysis","volume":"15","author":"Xiang","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jhepr.2025.101369_bib39","article-title":"Exploring the causality between hypothyroidism and non-alcoholic fatty liver: a Mendelian randomization study","volume":"9","author":"Qiu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101369_bib40","article-title":"The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"16","author":"D\u2019Ambrosio","year":"2021","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101369_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12902-021-00694-w","article-title":"Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Endocr Disord"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T07:23:38Z","timestamp":1746429818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2589555925000461"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101369","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid dysfunction in MASLD: Results of a nationwide study","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101369"}}